Skip to main content

Table 1 Characteristics of participants1 in relation to IDF-defined metabolic syndrome, the HUNT 2 study

From: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study

  Men Women
  No metabolic syndrome Metabolic syndrome No metabolic syndrome Metabolic syndrome
N (%) 3622 (71.1) 1479 (29.0) 3558 (69.7) 1547 (30.3)
Age, y 45.8 ± 16.6 55.0 ± 16.3 44.8 ± 16.1 60.2 ± 16.2
Systolic BP, mm Hg 136.9 ± 18.7 148.8 ± 19.9 130.1 ± 21.1 153.6 ± 24.3
Diastolic BP, mm Hg 81.2 ± 11.7 88.8 ± 11.7 77.1 ± 11.2 86.7 ± 12.9
Waist circumference, cm 88.2 ± 7.9 101.9 ± 7.3 77.4 ± 9.7 92.9 ± 9.9
HDL cholesterol, mmol/L 1.32 ± 0.33 1.10 ± 0.31 1.59 ± 0.37 1.30 ± 0.36
Triglycerides, mmol/L 1.31 ± 0.91 2.30 ± 1.40 0.99 ± 0.55 2.02 ± 1.15
Glucose, mmol/L 5.35 ± 0.93 5.93 ± 1.67 5.18 ± 0.60 5.98 ± 1.52
Type 2 diabetes, % 0.8 3.6 0.2 6.0
Antihypertensive medication, % 6.6 19.4 5.6 30.2
Waist/hip ratio 0.88 ± 0.05 0.95 ± 0.05 0.78 ± 0.05 0.85 ± 0.06
BMI, kg/m2 25.4 ± 3.0 29.8 ± 3.3 25.0 ± 4.1 30.2 ± 4.5
Total cholesterol, mmol/L 5.74 ± 1.17 6.25 ± 1.14 5.75 ± 1.29 6.69 ± 1.37
  1. Data are numbers, means ± standard deviation, or percentages.
  2. HUNT, the Nord-Trøndelag Health study; IDF, the International Diabetes Federation; BP, blood pressure; HDL, high-density lipoprotein; BMI, body mass index.
  3. 1Fasting ≥4 hours.